Generics Debate Escalates

Wechsler,Jill;

Article

Pharmaceutical Executive

February 1, 2001

Pharmaceutical Executive

Pharmaceutical Executive-12-01-2001

Volume0

Issue 0

Generics Debate Escalates

Author(s):

Jill Wechsler, Pharm Exec’s Washington Correspondent

Calls for change reflect that generic products are a therapeutic mainstay and that patients and providers want earlier access to inexpensive medicines.

Articles in this issue

States Target DTC Advertising

Transparent Moment

IFPMA Disputes Doctors Without Boarders Report

GSK at Odds with Activists

Protecting People Everywhere

Opening the Door to Japan

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Generics Debate Escalates

Newsletter